SCIENTIFIC BACKGROUND

APC, CDH1, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, KIT, KRAS, MET, MLH1, MSH2, MSH6, NF1, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, PMS2, SMAD4, STK11, TP53

Category:

Scientific Background

Gastric cancer is a type of cancer that initiates from the cells in the lining of the stomach. Different factors, such as environmental and inheritance, can increase the risk of developing gastric cancer. Accumulation of mutations can result in the transformation of healthy cells into cancerous cells that will divide uncontrollably forming a tumor mass. At advanced stages, the tumor can release circulating tumor DNA (ctDNA) in the blood which will contain all the genetic alterations responsible for cancer initiation and development. Identifying the genetic alterations in the ctDNA has many benefits, including better prognostic assessment as well as therapy selection guidance which is tailored to each patient.

 

Microsatellite instability (MSI) immunotherapy biomarker assessment is also included in this panel and has been shown to be implicated in gastric cancer. Evidence suggests that MSI high status is correlated with better prognosis in patients with gastric cancer as well as improved survival rates. The FDA/EMA approved drug pembrolizumab can be used as an immunotherapy option for MSI-high patients with gastric cancer.

 

How many genes are tested in this panel?

23 genes

 

Recommendations by professional bodies

ESMO recommends liquid biopsy testing for ERBB2 gene in patients with gastric cancer when tissue biopsy is not feasible or when fast results are necessary for therapy selection (Pascual et al., 2022; ESMO recommendations).

 

References and more information: 

 

Information obtained from professional bodies including National Cancer Institute, and World Cancer Research Fund International

Pascual J, Attard G, Bidard FC, Curigliano G, De Mattos-Arruda L, Diehn M, Italiano A, Lindberg J, Merker JD, Montagut C, Normanno N, Pantel K, Pentheroudakis G, Popat S, Reis-Filho JS, Tie J, Seoane J, Tarazona N, Yoshino T, Turner NC. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Ann Oncol. 2022 Aug;33(8):750-768. doi: 10.1016/j.annonc.2022.05.520. Epub 2022 Jul 6. PMID: 35809752.

Ratti M, Lampis A, Hahne JC, Passalacqua R, Valeri N. Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cell Mol Life Sci. 2018 Nov;75(22):4151-4162. doi: 10.1007/s00018-018-2906-9. Epub 2018 Sep 1. PMID: 30173350; PMCID: PMC6182336.

Polom K, Marrelli D, Smyth EC, Voglino C, Roviello G, Pascale V, Varas J, Vindigni C, Roviello F. The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients. Surg Innov. 2018 Apr;25(2):99-104. doi: 10.1177/1553350617751461. Epub 2018 Jan 5. PMID: 29303062.

GENES

APC, CDH1, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, KIT, KRAS, MET, MLH1, MSH2, MSH6, NF1, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, PMS2, SMAD4, STK11, TP53
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more